Predicting nerve damage in patients with diabetes and chronic kidney disease
Official title: Estimate the Risk of Diabetic and Uremic Peripheral Neuropathy Using Physical and Functional Testing
Run by Université catholique de l'Ouest · NCT06933108 · Data updated 2026-11-12
This study is trying to see if better tests can help find nerve damage earlier in people with diabetes and chronic kidney disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 60 Years to 80 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Université catholique de l'Ouest Academic / other |
| Locations | 1 site (Le Mans) |
| Status | Recruiting |
| Started | January 27, 2025 |
| Main results expected | May 2, 2025 |
| Study ends | May 2, 2025 |
| Registry record updated | April 18, 2025 |
| Trial ID | NCT06933108 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with CKD stage 4-5 or diabetes who can walk 20 meters and have a BMI under 35.
✕Probably not a fit
Patients currently on dialysis, with cognitive impairments, or those with significant musculoskeletal or neurological diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the risk of peripheral neuropathy in patients with chronic kidney disease (CKD) stages 3 and 4, as well as those with diabetes. It focuses on identifying the common complication of peripheral neuropathy, which affects a significant portion of these patients. The study will utilize functional testing methods to improve the accuracy of neuropathy screening, addressing the limitations of current diagnostic tests that are often subjective or only detect advanced stages of nerve damage.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and management of peripheral neuropathy in patients with diabetes and CKD.
How similar studies have gone: While the approach of using functional testing for neuropathy prediction is promising, it has not been extensively tested in similar studies, making this a novel investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * CKD stage 4-5 and / or diabetes (Type I or II) * Able to walk 20 m * BMI \< 35 Exclusion Criteria: * Currently or planning dialysis * Musculoskeletal, osteorarticular and neurological disease(s) * Cognitive impairment * Low-limb amputation
Where it's running
-
Centre Hospitalier Le Mans
Le Mans, France Recruiting
Study contacts
- Study coordinator: Giorgina Barbara Piccoli, Professor, Medical Doctor
- Email: gpiccoli@ch-lemans.fr
- Phone: 0243434343
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.